Strengthening of Pharmaceutical Industry (SPI)’ scheme
Part of: Prelims and GS-II Health and GS-III Economy
Context: Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers on Friday released guidelines for ‘Strengthening of Pharmaceutical Industry (SPI)’ scheme.
The scheme aims to address rising demand in terms of support required to existing Pharma clusters and MSMEs across the country to improve their productivity, quality and sustainability.
The Centre has assigned an outlay of ₹500 crore for the period from fiscal FY 21-22 to FY 25-26.
Key highlights of the scheme:
financial assistance to pharma clusters will be provided for the creation of Common Facilities to improve the quality and to ensure the sustainable growth of clusters.
To upgrade the production facilities of SMEs and MSMEs so as to meet national and international regulatory standards.
support for clusters for creation of common facilities with the focus on R&D Labs, Testing Laboratories, Effluent Treatment Plants
The units supported under this scheme is expected to act as Demonstration Firms for the pharma clusters and MSE Pharma Industries, to develop on quality and technology up-gradation fronts.
